Long-Term Follow-up Study for Patients Previously Treated With JCAR015

NCT02813252 · clinicaltrials.gov ↗

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

GENETIC: JCAR015

Sponsor

Juno Therapeutics, a Subsidiary of Celgene